NIH-funded research NIH-funded research

Understanding how venom develops in cephalopods and its potential medical uses

Official title: Charting the evolutionary development of novel genes and the molecular mechanisms of gland tissue organizationin cephalopods

Funded at Hunter College · NIH-10932134 · Data updated 2026-11-12

This study is looking at how cephalopods, like octopuses and squids, develop their venom and how we might use that knowledge to create new medicines that could help treat different health issues.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHunter College
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$1,099,000
NIH project number5DP1AT012812-02
Project IDNIH-10932134 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals suffering from conditions that could benefit from venom-derived therapeutics, such as chronic pain or cancer.

Less likely to help

Patients with conditions unrelated to the therapeutic applications of venom, or those not responsive to venom-derived treatments, may not benefit from this research.

What this research studies

This research investigates the evolutionary development of venom in cephalopods, focusing on the molecular mechanisms that organize gland tissues responsible for venom production. By studying these processes, the research aims to create robust models for manipulating venom glands and understanding the regulation of venom bioactive compounds. This could lead to the discovery of new therapeutic agents derived from venom, which may be used to treat various medical conditions. The approach combines genetic manipulation and biological modeling to explore the untapped potential of venom in medicine.

Why it matters

Potential benefit: If successful, this research could lead to the development of new, effective treatments for conditions such as pain, diabetes, and cancer.

How similar studies have gone: Other research has shown success in utilizing venom-derived compounds for therapeutic purposes, indicating a promising avenue for further exploration.

Where this research is happening

  • Hunter College
    New York, United States
    Active

Researchers

  • Principal investigator: Holford, Mande N. — Hunter College
  • Study coordinator: Holford, Mande N.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.